Cargando…
High-sensitivity Troponin T in hemodialysis patients: a randomized placebo-controlled sub-study investigating angiotensin-II-blockade, variation over time and associations with clinical outcome
BACKGROUND: Troponin T (TnT) is a well-known risk factor for negative outcome in hemodialysis (HD) patients, but little is known about variation over time, and the impact of clinical and dialysis specific factors. This study investigated the effect of angiotensin II receptor blockade (ARB), short an...
Autores principales: | Peters, Christian D., Kjaergaard, Krista D., Christensen, Kent L., Bibby, Bo M., Jespersen, Bente, Jensen, Jens D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594269/ https://www.ncbi.nlm.nih.gov/pubmed/33115436 http://dx.doi.org/10.1186/s12882-020-02103-1 |
Ejemplares similares
-
Short and Long-Term Effects of the Angiotensin II Receptor Blocker Irbesartan on Intradialytic Central Hemodynamics: A Randomized Double-Blind Placebo-Controlled One-Year Intervention Trial (the SAFIR Study)
por: Peters, Christian Daugaard, et al.
Publicado: (2015) -
Preserving residual renal function in dialysis patients: an update on evidence to assist clinical decision making
por: Kjaergaard, Krista Dybtved, et al.
Publicado: (2011) -
Angiotensin II receptor blockade is associated with preserved muscle strength in chronic hemodialysis patients
por: Lin, Yu-Li, et al.
Publicado: (2019) -
The dual blockade of the renin–angiotensin system in hemodialysis patients requires decreased dialysate sodium concentration
por: Zwiech, Rafał, et al.
Publicado: (2012) -
The effectiveness and safety of angiotensin-converting enzyme inhibition or receptor blockade in vascular diseases in patients with hemodialysis
por: Liao, Kuang-Ming, et al.
Publicado: (2017)